Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 26 results.
User Information
Export Records
  1. 1.   Potent dual block to HIV-1 infection using lentiviral vectors expressing fusion inhibitor peptide mC46- and Vif-resistant APOBEC3G
  2. Frankenberry,Krista; Ojha, Chet R; Hermann, Kip J; Hu,Wei-Shau; Torbett, Bruce E; Pathak,Vinay
  3. Molecular Therapy. Nucleic Acids. 2023, Sep 12; 33: 794-809.
  1. 2.   Interactions of APOBEC3s with DNA and RNA
  2. Maiti, Atanu; Hou, Shurong; Schiffer, Celia A.; Matsuo,Hiroshi
  3. Current opinion in structural biology. 2021, Apr; 67: 195-204.
  1. 3.   Structural Insights into APOBEC3-Mediated Lentiviral Restriction
  2. Delviks-Frankenberry, Krista A.; Desimmie, Belete A.; Pathak,Vinay
  3. Viruses. 2020, JUN; 12(6):
  1. 4.   Development of Lentiviral Vectors for HIV-1 Gene Therapy with Vif-Resistant APOBEC3G
  2. Frankenberry,Krista; Ackerman, Daniel; Timberlake, Nina D; Hamscher, Maria; Nikolaitchik,Olga; Hu,Wei-Shau; Torbett, Bruce E; Pathak,Vinay
  3. Molecular therapy. Nucleic acids. 2019, Dec 6; 18: 1023-1038.
  1. 5.   A Custom 148 Gene-Based Resequencing Chip and the SNP Explorer Software: New Tools to Study Antibody Deficiency
  2. Wang, H. Y.; Gopalan, V.; Aksentijevich, I.; Yeager, M.; Ma, C. A.; Mohamoud, Y. A.; Quinones, M.; Matthews, C.; Boland, J.; Niemela, J. E.; Torgerson, T. R.; Giliani, S.; Uzel, G.; Orange, J. S.; Shapiro, R.; Notarangelo, L.; Ochs, H. D.; Fleisher, T.; Kastner, D.; Chanock, S. J.; Jain, A.
  3. Human Mutation. 2010, Sep; 31(9): 1080-1088.
  1. 6.   APOBEC3G expression is dysregulated in primary HIV-1 infection and polymorphic variants influence CD4+ T-cell counts and plasma viral load
  2. Reddy, K.; Winkler, C. A.; Werner, L.; Mlisana, K.; Karim, S. S. A.; Ndung'u, T.; Team, C. A. I. S.
  3. Aids. 2010, Jan; 24(2): 195-204.
  1. 7.   Likely Role of APOBEC3G-Mediated G-to-A Mutations in HIV-1 Evolution and Drug Resistance
  2. Jern, P.; Russell, R. A.; Pathak, V. K.; Coffin, J. M.
  3. Plos Pathogens. 2009 5(4):
  1. 8.   AID expression levels determine the extent of cMyc oncogenic translocations and the incidence of B cell tumor development
  2. Takizawa, M.; Tolarova, H.; Li, Z.; Dubois, W.; Lim, S.; Callen, E.; Franco, S.; Mosaico, M.; Feigenbaum, L.; Alt, F. W.; Nussenzweig, A.; Potter, M.; Casellas, R.
  3. Journal of Experimental Medicine. 2008 205(9): 1949-1957.
  1. 9.   Human immunodeficiency virus type 1 cDNAs produced in the presence of APOBEC3G exhibit defects in plus-strand DNA transfer and integration
  2. Mbisa, J. L.; Barr, R.; Thomas, J. A.; Vandegraaff, N.; Dorweiler, I. J.; Svarovskaia, E. S.; Brown, W. L.; Mansky, L. M.; Gorelick, R. J.; Harris, R. S.; Engelman, A.; Pathak, V. K.
  3. Journal of Virology. 2007, Jul; 81(13): 7099-7110.
  1. 10.   Regulation of AID expression in the immune response
  2. Crouch, E. E.; Li, Z. Y.; Takizawa, M.; Fichtner-Feigl, S.; Gourzi, P.; Montano, C.; Feigenbaum, L.; Wilson, P.; Janz, S.; Papavasiliou, F. N.; Casellas, R.
  3. Journal of Experimental Medicine. 2007, May; 204(5): 1145-1156.
  1. 11.   Stoichiometry of the antiviral protein APOBEC3G in HIV-1 virions
  2. Xu, H. Z.; Chertova, E.; Chen, J. B.; Ott, D. E.; Roser, J. D.; Hu, W. S.; Pathak, V. K.
  3. Virology. 2007, Apr; 360(2): 247-256.
  1. 12.   Resistance of human T cell leukemia virus type 1 to APOBEC3G restriction is mediated by elements in nucleocapsid
  2. Derse, D.; Hill, S. A.; Princler, G.; Lloyd, P.; Heidecker, G.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2007, Feb; 104(8): 2915-2920.
  1. 13.   Activation-induced deaminase cloning, localization, and protein extraction from young V-H-Mutant rabbit appendix
  2. Yang, G. B.; Obiakor, H.; Sinha, R. K.; Newman, B. A.; Hood, B. L.; Conrads, T. P.; Veenstra, T. D.; Mage, R. G.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2005, NOV 22; 102(47): 17083-17088.
  1. 14.   Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging
  2. Luo, K.; Liu, B. D.; Xiao, Z. X.; Yu, Y. K.; Yu, X. H.; Gorelick, R.; Yu, X. F.
  3. Journal of Virology. 2004, NOV; 78(21): 11841-11852.
  1. 15.   APOBEC3G genetic variants and their influence on the progression to AIDS
  2. An, P.; Bleiber, G.; Duggal, P.; Nelson, G.; May, M.; Mangeat, B.; Alobwede, I.; Trono, D.; Vlahov, D.; Donfield, S.; Goedert, J. J.; Phair, J.; Buchbinder, S.; O'Brien, S. J.; Telenti, A.; Winkler, C. A.
  3. Journal of Virology. 2004, OCT; 78(20): 11070-11076.
  1. 16.   A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion
  2. Xu, H. Z.; Svarovskaia, E. S.; Barr, R.; Zhang, Y. J.; Khan, M. A.; Strebel, K.; Pathak, V. K.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2004 101(15): 5652-5657.
  1. 17.   Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome
  2. Yu, Q.; Konig, R.; Pillai, S.; Chiles, K.; Kearney, M.; Palmer, S.; Richman, D.; Coffin, J. M.; Landau, N. R.
  3. Nature Structural & Molecular Biology. 2004 11(5): 435-442.
  1. 18.   Autologous lymphoma vaccines induce human T cell responses against multiple, unique epitopes
  2. Baskar, S.; Kobrin, C. B.; Kwak, L. W.
  3. Journal of Clinical Investigation. 2004 113(10): 1498-1510.
  1. 19.   Weapons of mutational destruction
  2. KewalRamani, V. N.; Coffin, J. M.
  3. Science. 2003 301(5635): 923-925.
  1. 20.   Error-prone DNA polymerases: When making a mistake is the only way to get ahead
  2. Rattray, A. J.; Strathern, J. N.
  3. Annual Review of Genetics. 2003 37: 31-66.
  1. 21.   The roles of REV3 and RAD57 in double-strand-break-repair- induced mutagenesis of Saccharomyces cerevisiae
  2. Rattray, A. J.; Shafer, B. K.; McGill, C. B.; Strathern, J. N.
  3. Genetics. 2002 162(3): 1063-1077.
  1. 22.   The palm subdomain-based active site is internally permuted in viral RNA-dependent RNA polymerases of an ancient lineage
  2. Gorbalenya, A. E.; Pringle, F. M.; Zeddam, J. L.; Luke, B. T.; Cameron, C. E.; Kalmakoff, J.; Hanzlik, T. N.; Gordon, K. H. J.; Ward, V. K.
  3. Journal of Molecular Biology. 2002 324(1): 47-62.
  1. 23.   Construction and characterization of a replication-competent retroviral shuttle vector plasmid
  2. Oh, J.; Julias, J. G.; Ferris, A. L.; Hughes, S. H.
  3. Journal of Virology. 2002 76(4): 1762-1768.
  1. 24.   Design and initial characterization of a circular permuted variant of the potent HIV-inactivating protein cyanovirin-N
  2. Barrientos, L. G.; Louis, J. M.; Hung, J.; Smith, T. H.; O'Keefe, B. R.; Gardella, R. S.; Mori, T.; Boyd, M. R.; Gronenborn, A. M.
  3. Proteins-Structure Function and Genetics. 2002 46(2): 153-160.
  1. 25.   Novel secondary Ig V-H gene rearrangement and in-frame Ig heavy chain complementarity-determining region III insertion/deletion variants in de novo follicular lymphoma
  2. Kobrin, C. B.; Bendandi, M.; Kwak, L. W.
  3. Journal of Immunology. 2001 166(4): 2235-2243.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel